Back to Journals » Drug Design, Development and Therapy » Volume 13

Hesperidin: A Therapeutic Agent For Obesity

Authors Xiong H, Wang J, Ran Q, Lou G, Peng C, Gan Q, Hu J, Sun J, Yao R, Huang Q

Received 19 August 2019

Accepted for publication 23 October 2019

Published 12 November 2019 Volume 2019:13 Pages 3855—3866

DOI https://doi.org/10.2147/DDDT.S227499

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Professor Jianbo Sun


Haijun Xiong,1 Jin Wang,1 Qian Ran,1 Guanhua Lou,1 Chengyi Peng,1 Qingxia Gan,1 Ju Hu,1 Jilin Sun,2 Renchuan Yao,3 Qinwan Huang1,4

1School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People’s Republic of China; 2Sichuan Fuzheng Pharmaceutical Co. Ltd, Sichuan, People’s Republic of China; 3Sichuan Fermentation Traditional Chinese Medicine Engineering Research Center, Chengdu, People’s Republic of China; 4State Key Laboratory of Traditional Chinese Medicine Processing Technology, State Administration of Traditional Chinese Medicine, Chengdu 611137, People’s Republic of China

Correspondence: Qinwan Huang
College of Pharmacy, Chengdu University of Traditional Chinese Medicine, No. 1166, Liutai Road, Wenjiang District, Chengdu 611137, People’s Republic of China
Tel +86 13982199974
Fax +61800231
Email hqwan2163@163.com

Abstract: Obesity is a chronic metabolic disease caused by multiple factors and is considered to be a risk factor for type 2 diabetes, cardiovascular disease, hypertension, stroke and various cancers. Hesperidin, a flavanone glycoside, is a natural phenolic compound with a wide range of biological effects. Mounting evidence has demonstrated that hesperidin possesses inhibitory effect against obesity diseases. Our review discusses mechanisms of hesperidin in the treatment of obesity. Hesperidin regulates lipid metabolism and glucose metabolism by mediating AMPK and PPAR signaling pathways, directly regulates antioxidant index and anti-apoptosis, and indirectly mediates NF-κB signaling pathway to regulate inflammation to play a role in the treatment of obesity. In addition, hesperidin-enriched dietary supplements can significantly improve symptoms such as postprandial hyperglycemia and hyperlipidemia. Further clinical trials are also required for confirming lipid-lowering efficacy of this natural flavonoid and evaluating its safety profile.

Keywords: citrus flavonoids, lipid metabolism, glucose metabolism, anti-oxidation, anti-inflammatory

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]